Having clonogenic activities and being involved in several properties of hematopoietic stem cells, we assume the CCN3 hypermethylation as a candidate initiator of CML, which can provide the clonal domination of BCR-ABL+ cells. This evidence concerns the gene CCN3 and chronic myelogenous leukemia, BCR-ABL1 positive.